Table 2.
Low- and high-risk sTREM2 cut-offs for the prediction of outcome after liver surgery.
| PHLF | PHLF B+C | 90-day mortality | |
|---|---|---|---|
| Preop sTREM2 ≥3.452 (μg/ml) cut-off | |||
| Sens. | 80% | 85% | 80% |
| Spec. | 66% | 63% | 62% |
| PPV | 37% | 26% | 21% |
| NPV | 93% | 96% | 96% |
| p value | <0.001 | 0.001 | 0.011 |
| Preop sTREM2 ≥7.584 (μg/ml) cut-off | |||
| Sens. | 24% | 27% | 30% |
| Spec. | 98% | 97% | 96% |
| PPV | 67% | 50% | 50% |
| NPV | 86% | 91% | 91% |
| p value | 0.001 | 0.002 | 0.003 |
NPV, negative predictive value; PHLF, posthepatectomy liver failure; PPV, positive predictive value; Sens, sensitivity; Spec, specificity; sTREM2, soluble TREM2.
Bold formatting highlight the outcome parameters.